Unknown

Dataset Information

0

Use of zebrafish to model chemotherapy and targeted therapy gastrointestinal toxicity.

ABSTRACT:

SUBMITTER: Van Sebille YZ 

PROVIDER: S-EPMC6802154 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Use of zebrafish to model chemotherapy and targeted therapy gastrointestinal toxicity.

Van Sebille Ysabella Za YZ   Gibson Rachel J RJ   Wardill Hannah R HR   Carney Thomas J TJ   Bowen Joanne M JM  

Experimental biology and medicine (Maywood, N.J.) 20190611 14

Similar Datasets

Unknown Choroid plexus-CSF-targeted antioxidant therapy protects the brain from toxicity of cancer chemotherapy.
| S-EPMC9588748 | biostudies-literature
Genomics Chemotherapy-induced gastrointestinal toxicity and gut microbiota
| PRJEB35526 | ENA
Unknown Peptidoglycan Recognition Peptide 2 Aggravates Weight Loss in a Murine Model of Chemotherapy-Induced Gastrointestinal Toxicity.
| S-EPMC8021894 | biostudies-literature
Unknown Use of the zebrafish larvae as a model to study cigarette smoke condensate toxicity.
| S-EPMC4272283 | biostudies-literature
Unknown The management of gastrointestinal stromal tumors: a model for targeted and multidisciplinary therapy of malignancy.
| S-EPMC3381421 | biostudies-literature
Unknown Use of Shenhuang paste on Shenque point improves chemotherapy induced gastrointestinal toxicity in breast cancer: A protocol for randomized controlled trial.
| S-EPMC8052020 | biostudies-literature
Unknown Gastrointestinal Cancers with Consideration of DPD and UGT1A1 Plasma Levels: Chemotherapy-Related Toxicity.
| S-EPMC12300698 | biostudies-literature
Unknown Potential role of drug metabolizing enzymes in chemotherapy-induced gastrointestinal toxicity and hepatotoxicity.
| S-EPMC8059872 | biostudies-literature
Metabolomics Zebrafish Metabolomics: Model for Environmental Metal Toxicity
| ST000365 | MetabolomicsWorkbench
Unknown Allopurinol use during pediatric acute lymphoblastic leukemia maintenance therapy safely corrects skewed 6-mercaptopurine metabolism, improving inadequate myelosuppression and reducing gastrointestinal toxicity.
| S-EPMC8773437 | biostudies-literature